v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT05293236 |
Full text link
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
d.segarra@aptatargets.com |
Registration date
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
2022-03-24 |
Recruitment status
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
Recruiting |
Study design
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
Sequential assignment |
Masking
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
multi-center |
Study aim
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
inclusion criteria: men or women with age ≥18 and ≤85 years. in case of women of childbearing potential (wocbp), they should confirm menstrual period and a negative highly sensitive urine or serum pregnancy test to be included. laboratory-confirmed sars-cov-2 infection. informed consent obtained . hypoxia (spo2<95%). documented lung opacities/infiltrates. confirmed hyperinflammation. |
Exclusion criteria
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
onset of symptoms of covid-19 >14 days. pregnant or nursing (lactating) women. hospitalized >10 days for covid-19. need of high concentration non-rebreather mask, high-flow nasal cannula , non-invasive mechanical ventilation or invasive mechanical ventilation. systolic blood pressure < 90 mmhg. serious concomitant illness. recent treatment with cell-depleting therapies. enrolled in another clinical trial. severe renal dysfunction. in the opinion of the investigator, unable to comply with the requirements to participate in the study. |
Number of arms
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
4 |
Funding
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
Macarena Hernández Jiménez |
Inclusion age min
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
85 |
Countries
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
Spain |
Type of patients
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
Moderate disease at enrollment |
Severity scale
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
3: Moderate disease at enrollment |
Total sample size
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
30 |
primary outcome
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
Incidence of Adverse Events as assessed by MedDRA;Incidence of Death;Number of patients with treatment-related alterations coagulation parameters;Number of patients with treatment-related alterations Complement Factors |
Notes
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
Phase 1 |
Arms
Last imported at : March 27, 2022, 4 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "0,05 mg/kg", "treatment_id": 2408, "treatment_name": "Aptoll", "treatment_type": "Other targeted therapies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "0,1 mg/kg", "treatment_id": 2408, "treatment_name": "Aptoll", "treatment_type": "Other targeted therapies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "0,2 mg/kg", "treatment_id": 2408, "treatment_name": "Aptoll", "treatment_type": "Other targeted therapies", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |